Catherine Do Email & Phone Number

Nutley, New Jersey, États-Unis

- Analyzed and interpreted high-throughput genomic and biomedical data- Designed, developed and deployed robust workflows, as well as custom scripts, to analyze high-throughput data, with emphasis on next-generation sequencing data (e.g. bisulfite-converted whole genomes).- Directed the implementation of a specific workflow that led to a 10x improvement in CPU-hours.- Developed these workflows on both cloud-based infrastructures and local clusters.- Mined proprietary and public biological data/database to generate novel hypotheses or insights- Built and managed proprietary biological databases (enriched NGS data).- Trained and supervised a team of physicians, bioinformaticians, & molecular biologists (BS to MD/PhD level).- Co-led complex, NIH-funded research projects with principal investigators at top-tier universities (e.g. Columbia University).- Wrote manuscripts for peer-reviewed journals (e.g. Genome Biology, Blood, Bioinformatics, etc.) & answered reviewers’ questions.- Co-wrote grant applications for NIH resulting in high scores or funding.

New York, New York, Usa

- On top of research responsibilities, oversaw and led the epigenetic core facility: interfaced with multiple principal investigators and supported them in their research (design & analysis)

Région De New York City , États-Unis

- Conducted processing and analyses of next generation sequencing and array data using R, STATA in Linux and cluster environment - Studied epigenetic modifications involved in cancers and complex human diseases to identify biomarkers, therapeutic targets and epigenetic risk factors - Studied mechanisms of haplotype-dependent methylation and identified common genetic variants associated with methylation changes- Supervised under- and graduated summer students- Designed epigenetic studies using targeted bisulfite sequencing (MiSeq-Fluidigm pipeline) and set up bioinformatics pipelines for pre- and post-processing analysis.

Région De Saint-Denis, France

- Assessed risk management plans submitted by pharmaceutical companies in the context of national and European marketing authorization procedures- Identified safety concerns from pre- or post-authorization data- Proposed pharmacovigilance activities and interventions designed to identify, characterize, prevent or minimize risks- Assessed protocols and results of post marketing observational studies

Région De Toulouse, France

Six-month rotations in the regional oncology network, the departments of medical database management, epidemiology, pathology, fertility and sterility, clinical research, pharmacovigilance.- Participated to clinical and research activities- Conducted, analyzed and interpreted observational studies- Designed and provided statistical and methodological support for epidemiologic, outcome research studies and evaluation of health care interventions- Supervised medical interns- Out of Reunion island, contributed to the implementation of enhanced influenza surveillance in Reunion Island during the emergence of the pandemic A(H1N1)v influenza- Collected, analyzed and interpreted data from seasonal and pandemic Influenza

Phnom Penh, Cambodia

Six-month rotation in the Malaria Molecular Epidemiology Unit• Implemented Plasmodium Vivax culture and DNA isolation for whole genome sequencing

Région De Toulouse, France

• Investigated the pro-oncogenic role of progastrine in colorectal cancer• Designed and conducted a retrospective cohort study to assessed the role of progastrine as a biomarker for early detection of colorectal cancer

Doctor Of Philosophy (Phd), Cellular And Molecular Biology

Doctor Of Medicine (Md), Public Health/Epidemiology

Master Of Science (M.Sc.), Biostatistics/Pharmacology

Visitor Student, Music

Baccalauréat